UVA Health is among the first in the U.S. to offer BiTE therapy to small cell lung cancer patients in the outpatient setting.
Category: Oncology Innovations
UVA Health is the first Virginia healthcare provider to offer tarlatamab for small cell lung cancer patients. The FDA recently approved this new treatment in the second line setting for patients with stage 4 disease.
Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.
This tool guides women on when to add MRI to their breast cancer screening regiment.
Dr. Duska's goal is for every GYN cancer patient at UVA Health to have the opportunity to participate in a clinical trial.
The discovery of an unexpected oocyte protein on the surface of cancer cells may lead to new treatments for pancreatic, ovarian, and other cancers.
UVA Cancer Center researchers lead acute myeloid leukemia (AML) discovery that could pave the way for improved treatments and patient outcomes.
Two new brain tumor medications could make a significant difference in the way tumors are treated — and in the lives of patients.
Learn how her research could lead to new and better life-saving treatments for ovarian and pancreatic cancers.
Endobiliary ablation can extend survival for patients with conditions like cholangiocarcinoma and pancreatic cancers.